Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain

Treatment patterns for metastatic colorectal cancer in Spain

(2020) E. Aranda et al.   Clinical & Translational Oncology

SEOM clinical guideline for treatment of kidney cancer (2019)

(2020) M. Lázaro et al.   Clinical & Translational Oncology

Medicamentos biosimilares: medidas para fomentar su uso

(2019) Josep Maria Guiu Segura et al.   MEDICINA CLINICA

Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)

(2019) Mariano Provencio et al.   Translational Lung Cancer Research

SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)

(2018) M. Majem et al.   Clinical & Translational Oncology

Bevacizumab in Metastatic, Recurrent, or Persistent Cervical Cancer: The BC Cancer Experience

(2018) Anna V. Tinker et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) J. A. Ledermann et al.   ANNALS OF ONCOLOGY

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

(2013) Dorien J. A. Lobbezoo et al.   BREAST CANCER RESEARCH AND TREATMENT

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer

(2013) Israel Zighelboim et al.   GYNECOLOGIC ONCOLOGY

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

(2013) Sean D. Sullivan et al.   VALUE IN HEALTH

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

(2010) Brian I. Rini et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

(2007) Suresh S. Ramalingam et al.   JOURNAL OF CLINICAL ONCOLOGY